Source link : https://newshealth.biz/health-news/fda-okays-car-t-cell-therapy-for-marginal-zone-lymphoma/
Liso-cel now has five approved indications, the most of any CD19-targeted CAR T-cell therapy. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-okays-car-t-cell-therapy-marginal-zone-lymphoma-2025a1000y5g?src=rss Author : Publish date : 2025-12-05 16:22:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Okays CAR T-Cell Therapy for Marginal Zone Lymphoma first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-05 16:22:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8